×
Increased Risk for Suicidal Behavior in Comorbid Bipolar Disorder and Alcohol Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF
$ 40.00
Increased Risk for Suicidal Behavior in Comorbid Bipolar Disorder and Alcohol Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF quantity
$ 40.00
×
Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials PDF
$ 40.00
Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials PDF quantity
$ 40.00
×
Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence PDF
$ 40.00
Double-Blind, Randomized Comparison of Memantine and Escitalopram for the Treatment of Major Depressive Disorder Comorbid With Alcohol Dependence PDF quantity
$ 40.00
×
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment PDF
$ 40.00
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment PDF quantity
$ 40.00
×
Epidemiology of Depressive Disorders in Patients With Liver Cirrhosis: A Population-Based Study in the United States PDF
$ 40.00
Epidemiology of Depressive Disorders in Patients With Liver Cirrhosis: A Population-Based Study in the United States PDF quantity
$ 40.00
×
Antipsychotic Treatment and the Occurrence of Venous Thromboembolism: A 10-Year Nationwide Registry Study PDF
$ 40.00
Antipsychotic Treatment and the Occurrence of Venous Thromboembolism: A 10-Year Nationwide Registry Study PDF quantity
$ 40.00
×
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) PDF
$ 40.00
Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017) PDF quantity
$ 40.00
×
BL-1020, a New γ-Aminobutyric Acid-Enhanced Antipsychotic: Results of 6-Week, Randomized, Double-Blind, Controlled, Efficacy and Safety Study PDF
$ 40.00
BL-1020, a New γ-Aminobutyric Acid-Enhanced Antipsychotic: Results of 6-Week, Randomized, Double-Blind, Controlled, Efficacy and Safety Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart